NCT05392907

Forensic-medical Aspects of Lower Limb Prosthetics: An Observational Study

Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro·ClinicalTrials.govCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Amputation
Study type
Observational
Sponsor & location
Primary sponsor
Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro
Location
Budrio, Italy
Timeline & enrollment
Phase
N/A
Start date
Oct 23, 2020
End date
Jul 23, 2021
Enrollment
50 participants
Primary outcome

Questionnaire: Trinity Amputation Prosthesis Experience Scale (TAPES)

Summary

The study investigated the perceived-mobility of patients with unilateral lower limb
 amputations by means of patient-reported outcome measures (PROMs). Such aspect may play an
 important role in evaluating the patient impairment and addressing forensic-medical issues.
 However, to this concern, the use of PROMs has not been extensively investigated yet. Among
 the validated PROMs, the study assessed self-perceived mobility and quality of life by
 administering the Trinity Amputation Prosthetic Evaluation Survey (TAPES) and the more recent
 Prosthetic Mobility Questionnaire (PMQ). The aim of this observational study was to improve
 the estimation of the physical and psychological impairment caused by the amputation,
 focusing on the impact of the limb loss on social participation, quality of life and daily
 living activities.

ICD-10 classifications
Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05392907
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05392907 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro and is currently Completed. The study focuses on Amputation. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.